Mixed options sentiment in Pfizer (PFE), with shares down 2c near $24.55. Options volume relatively light with 39k contracts traded and calls leading puts for a put/call ratio of 0.49, compared to a typical level near 0.6. Implied volatility (IV30) dropped 0.34 near 19.26,in the lowest 10% of observations over the past year, suggesting an expected daily move of $0.30. Put-call skew flattened, suggesting a modestly bullish tone.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Abrocitinib Study: A Potential Game-Changer for Atopic Dermatitis Treatment
- Pfizer and Astellas Pharma’s Prostate Cancer Study: A Potential Game-Changer?
- Pfizer’s New Study on Inotuzumab Ozogamicin: A Potential Game-Changer in Pediatric Leukemia Treatment
- Pfizer’s MagnetisMM-4 Study: A New Hope for Multiple Myeloma Treatment
- Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: Key Insights for Investors